TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
TFF Pharmaceuticals Inc. (TFFP) Tops Q1 EPS by 4c
May 14, 2020 4:13 PM EDTTFF Pharmaceuticals Inc. (NASDAQ: TFFP) reported Q1 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24).
This has been another quarter of major accomplishment for TFF Pharmaceuticals, said Glenn Mattes, President and CEO of TFF Pharmaceuticals. Weve maintained the clinical momentum behind our two lead programs, Voriconazole Inhalation Powder, the first clinical study ever in healthy subjects of a direct-to-lung, Thin Film Freezing (TFF) dry-powder formulation, and... More
